Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Triple Negative Breast Neoplasms × Capecitabine × Clear all

Status

Sponsor Class

Study Type

Interventional 63 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Rectal Neoplasms 10 Colorectal Neoplasms 10 Stomach Neoplasms 3 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Recurrence 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Metastasis 1 Microbiota 1 Gallbladder Neoplasms 1 Fruquintinib 1 Elderly Metastatic Colorectal Cancer Patients 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Cancer Organoids 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Ampullary Adenocarcinoma 1

Interventions

Blood Specimen Collection 4 Drug Therapy 3 Specimen Handling 2 Immune Checkpoint Inhibitors 2 Carboplatin 2 Biopsy, Large-Core Needle 2 Biopsy 2 toripalimab 1 tislelizumab 1 taxane 1 sacituzumab govitecan 1 pembrolizumab 1 atezolizumab 1 Zoledronic Acid 1 Urine Specimen Collection 1 Prophylactic Mastectomy 1 Paracentesis 1 Neuropsychological Tests 1 Mifepristone 1 Medicine, Chinese Traditional 1 Mastectomy, Segmental 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Interviews as Topic 1 Immunotherapy 1 Immunohistochemistry 1 Gene Expression Profiling 1 Doxorubicin 1 DNA 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06700382 2024-11-25

NeoTNBCX

Peking University People's Hospital

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡